+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Eluting Stent"

Global Drug-Eluting Stents Market - Product Thumbnail Image

Global Drug-Eluting Stents Market

  • Report
  • November 2020
  • 127 Pages
  • Global
From
Global Markets for Drug-Device Combinations - Product Thumbnail Image

Global Markets for Drug-Device Combinations

  • Report
  • January 2022
  • 101 Pages
  • Global
From
From
Stents: Technologies and Global Markets 2022-2027 - Product Thumbnail Image

Stents: Technologies and Global Markets 2022-2027

  • Report
  • June 2022
  • 152 Pages
  • Global
From
From
Indonesia Stent Market, Competition, Forecast & Opportunities, 2028 - Product Thumbnail Image

Indonesia Stent Market, Competition, Forecast & Opportunities, 2028

  • Report
  • October 2023
  • 80 Pages
  • Indonesia
From
From
From
From
Coronary Stents-Pipeline Insight and Competitive Landscape, 2022 - Product Thumbnail Image

Coronary Stents-Pipeline Insight and Competitive Landscape, 2022

  • Drug Pipelines
  • July 2022
  • 60 Pages
  • Global
From
From
From
From
From
Drug Eluting Implants Market - Forecasts from 2021 to 2026 - Product Thumbnail Image

Drug Eluting Implants Market - Forecasts from 2021 to 2026

  • Report
  • July 2021
  • 111 Pages
  • Global
From
Loading Indicator

The Drug Eluting Stent (DES) market is a subset of the drug delivery market. DES are medical devices used to treat coronary artery disease. They are inserted into the artery and release a drug over time to prevent the artery from narrowing again. The DES market has grown in recent years due to the increasing prevalence of cardiovascular diseases and the need for more effective treatments. The DES market is expected to continue to grow as new technologies are developed and the demand for more effective treatments increases. Some of the major players in the DES market include Abbott, Boston Scientific, Medtronic, Biotronik, and Terumo. Show Less Read more